Lichen Depsidones with Biological Interest

 

 Permissions and Reprints

Abstract

Depsidones are some of the most abundant secondary metabolites produced by lichens. These compounds have aroused great pharmacological interest due to their activities as antioxidants, antimicrobial, and cytotoxic agents. Hence, this paper aims to provide up-to-date knowledge including an overview of the potential biological interest of lichen depsidones. So far, the most studied depsidones are fumarprotocetraric acid, lobaric acid, norstictic acid, physodic acid, salazinic acid, and stictic acid. Their pharmacological activities have been mainly investigated in in vitro studies and, to a lesser extent, in in vivo studies. No clinical trials have been performed yet. Depsidones are promising cytotoxic agents that act against different cell lines of animal and human origin. Moreover, these compounds have shown antimicrobial activity against both Gram-positive and Gram-negative bacteria and fungi, mainly Candida spp. Furthermore, depsidones have antioxidant properties as revealed in oxidative stress in vitro and in vivo models. Future research should be focused on further investigating the mechanism of action of depsidones and in evaluating new potential actions as well as other depsidones that have not been studied yet from a pharmacological perspective. Likewise, more in vivo studies are prerequisite, and clinical trials for the most promising depsidones are encouraged.

Publication History

Received: 09 March 2021

Accepted after revision: 13 April 2021

Article published online:
25 May 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Aschenbrenner IA, Cernava T, Berg G, Grube M. Understanding microbial multi-species symbioses. Front Microbiol 2016; 7: 180 DOI: 10.3389/fmicb.2016.00180.
  CrossrefPubMedGoogle Scholar
• 2 Calcott MJ, Ackerley DF, Knight A, Keysers RA, Owen JG. Secondary metabolism in the lichen symbiosis. Chem Soc Rev 2018; 47: 1730-1760 DOI: 10.1039/c7cs00431a.
  CrossrefPubMedGoogle Scholar
• 3 Ivanova D, Ivanov D. Ethnobotanical use of lichens: lichens for food review. Scr Sci Med 2009; 41: 11 DOI: 10.14748/ssm.v41i1.456.
  CrossrefPubMedGoogle Scholar
• 4 Singh H, Husain T, Agnihotri P, Pande PC, Khatoon S. An ethnobotanical study of medicinal plants used in sacred groves of Kumaon Himalaya, Uttarakhand, India. J Ethnopharmacol 2014; 154: 98-108 DOI: 10.1016/j.jep.2014.03.026.
  Google Scholar
• 5 Devkota S, Chaudhary R, Werth S, Scheidegger C. Indigenous knowledge and use of lichens by the lichenophilic communities of the Nepal Himalaya. J Ethnobiol Ethnomed 2017; 13: 1-10 DOI: 10.1186/s13002-017-0142-2.
  Google Scholar
• 6 Molnár K, Farkas E. Current results on biological activities of lichen secondary metabolites: A review. Z Naturforsch C J Biosci 2010; 65: 157-173 DOI: 10.1515/znc-2010-3-401.
  CrossrefPubMedGoogle Scholar
• 7 Furmanek Ł, Czarnota P, Seaward MRD. Antifungal activity of lichen compounds against dermatophytes: a review. J Appl Microbiol 2019; 127: 308-325 DOI: 10.1111/jam.14209.
  CrossrefPubMedGoogle Scholar
• 8 Rankovic B, Kosanic M. Lichens as a Potential Lichen Source of bioactive secondary Metabolites. In: Rankovic B. ed. Lichen secondary Metabolites. Bioactive Properties and pharmaceutical Potential. Cham, Switzerland: Springer International; 2015: 1-26
  Google Scholar
• 9 Nash TH, Ryan BD, Gries C, Bungartz F. Lichen Flora of the greater Sonoran Desert Region. Dexter, MI: Arizona State University, Thomas-shore, Inc.; 2002
  Google Scholar
• 10 Fernández-Moriano C, Gómez-Serranillos MP, Crespo A. Antioxidant potential of lichen species and their secondary metabolites. A systematic review. Pharm Biol 2016; 54: 1-17 DOI: 10.3109/13880209.2014.1003354.
  CrossrefPubMedGoogle Scholar
• 11 Solárová Z, Liskova A, Samec M, Kubatka P, Büsselberg D, Solár P. Anticancer potential of lichensʼ secondary metabolites. Biomolecules 2020; 10: 87 DOI: 10.3390/biom10010087.
  CrossrefPubMedGoogle Scholar
• 12 Piovano M, Garbarino JA, Giannini FA, Correché ER, Feresin G, Tapia A, Zacchino S, Enriz RD. Evaluation of antifungal and antibacterial activities of aromatic metabolites from lichens. Bol Soc Chil Quím 2002; 47: 235-240 DOI: 10.4067/S0366-16442002000300006.
  CrossrefPubMedGoogle Scholar
• 13 Podterob A. Chemical composition of lichens and their medical applications. Pharm Chem J 2008; 42: 582-588 DOI: 10.1007/s11094-009-0183-5.
  CrossrefPubMedGoogle Scholar
• 14 Shukla V, Joshi GP, Rawat MSM. Lichens as a potential natural source of bioactive compounds: A review. Phytochem Rev 2010; 9: 303-314 DOI: 10.1007/s11101-010-9189-6.
  CrossrefPubMedGoogle Scholar
• 15 Vickery ML, Vickery B. Polyketides. In: Secondary Plant Metabolism. London: MacMillan Press; 1981: 88-111
  Google Scholar
• 16 Legaz M, de Armas R, Vicente C. Bioproduction of Depsidones for pharmaceutical Purposes. In: Rundfeldt C. ed. Drug Development–A case Study based Insight into modern Strategies. InTech; 2011. DOI: 10.5772/27051 Accessed November 1, 2020 at: http://www.intechopen.com/books/drug-development-a-case-study-based-insight-into-modern-strategies/bioproduction-of-depsidones-for-pharmaceutical-purposes
  CrossrefGoogle Scholar
• 17 Ibrahim SRM, Mohamed GA, Al Haidari RA, El Kholy AA, Zayed MF, Khayat MT. Biologically active fungal depsidones: chemistry, biosynthesis, structural characterization, and bioactivities. Fitoterapia 2018; 129: 317-365 DOI: 10.1016/j.fitote.2018.04.012.
  CrossrefPubMedGoogle Scholar
• 18 Correché ER, Enriz RD, Piovano M, Giannini F, Garbarino J, Enriz D. Cytotoxic and apoptotic effects on hepatocytes of secondary metabolites obtained from lichens. Altern Lab Anim 2004; 32: 605-615 DOI: 10.1177/026119290403200611.
  CrossrefPubMedGoogle Scholar
• 19 Manojlović N, Ranković B, Kosanić M, Vasiljević P, Stanojković T. Chemical composition of three Parmelia lichens and antioxidant, antimicrobial and cytotoxic activities of some their major metabolites. Phytomedicine 2012; 19: 1166-1172 DOI: 10.1016/j.phymed.2012.07.012.
  CrossrefPubMedGoogle Scholar
• 20 Paluszczak J, Kleszcz R, Studzińska-Sroka E, Krajka-Kuźniak V. Lichen-derived caperatic acid and physodic acid inhibit Wnt signaling in colorectal cancer cells. Mol Cell Biochem 2018; 441: 109-124 DOI: 10.1007/s11010-017-3178-7.
  CrossrefPubMedGoogle Scholar
• 21 Honegger R. Lichen-forming Fungi and their Photobionts. In: Deising HB. ed. Plant Relationships. The Mycota (A comprehensive Treatise on Fungi as experimental Systems for basic and applied Research). Berlin: Springer; 2009: 307-333
  Google Scholar
• 22 Brunauer G, Hager A, Grube M, Türk RM, Stocker-Wörgötter E. Alterations in secondary metabolism of aposymbiotically grown mycobionts of Xanthoria elegans and cultured resynthesis stages. Plant Physiol Biochem 2007; 45: 146-151 DOI: 10.1016/j.plaphy.2007.01.004.
  CrossrefPubMedGoogle Scholar
• 23 Elshobary ME, Osman ME, Abo-Shady AM, Komatsu E, Perreault H, Sorensen J, Piercey-Normore MD. Algal carbohydrates affect polyketide synthesis of the lichen-forming fungus Cladonia rangiferina . Mycologia 2016; 108: 646-656 DOI: 10.3852/15-263.
  CrossrefPubMedGoogle Scholar
• 24 Díaz E, Zamora J, Ruibal C, Divakar PK, González-Benítez N, Le Devehat F, Chollet M, Ferron S, Sauvager A, Boustie J, Crespo A, Molina MC. Axenic culture and biosynthesis of secondary compounds in lichen symbiotic fungi, the Parmeliaceae. Symbiosis 2020; 82: 1-15 DOI: 10.1007/s13199-020-00719-3.
  CrossrefPubMedGoogle Scholar
• 25 Gauslaa Y, Bidussi M, Solhaug KA, Asplund J, Larsson P. Seasonal and spatial variation in carbon based secondary compounds in green algal and cyanobacterial members of the epiphytic lichen genus Lobaria. Phytochemistry 2013; 94: 91-98 DOI: 10.1016/j.phytochem.2013.04.003.
  CrossrefPubMedGoogle Scholar
• 26 Nguyen KH, Chollet-Krugler M, Gouault N, Tomasi S. UV-protectant metabolites from lichens and their symbiotic partners. Nat Prod Rep 2013; 30: 1490-1508 DOI: 10.1039/c3np70064j.
  CrossrefPubMedGoogle Scholar
• 27 Stocker-Wörgötter E. Biochemical Diversity and Ecology of Lichen-forming Fungi: Lichen Substances, chemosyndromic Variation and Origin of Polyketide-Type Metabolites (biosynthetic Pathways). In: Upreti DK, Divakar PK, Shukla V, Bajpai R. eds. Recent Advances in Lichenology: Modern Methods and Approaches in Lichen Systematics and Culture Techniques, Volume 2. New Delhi: Springer; 2015: 161-180
  Google Scholar
• 28 Parrot D, Legrave N, Delmail D, Grube M, Suzuki M, Tomasi S. Review – Lichen-associated bacteria as a hot spot of chemodiversity: Focus on uncialamycin, a promising compound for future medicinal applications. Planta Med 2016; 82: 1143-1152 DOI: 10.1055/s-0042-105571.
  Article in Thieme ConnectPubMedGoogle Scholar
• 29 Hawksworth D, Grube M. Lichens redefined as complex ecosystems. New Phytol 2020; 227: 1281-1283 DOI: 10.1111/nph.16630.
  CrossrefPubMedGoogle Scholar
• 30 Smith H, Dal Grande F, Muggia L, Keuler R, Divakar PK, Grewe F, Schmitt I, Thorsten Lumbsch H, Leavitt SD. Metagenomic data reveal diverse fungal and algal communities associated with the lichen. Symbiosis 2020; 82: 133-147 DOI: 10.1101/2020.03.04.966853.
  CrossrefPubMedGoogle Scholar
• 31 Mosbach K. Biosynthesis of lichen substances, products of a symbiotic association. Angew Chem 1969; 8: 240-250 DOI: 10.1002/anie.196902401.
  CrossrefPubMedGoogle Scholar
• 32 Elix JA, Stocker-Wörgötter E. Biochemistry and secondary Metabolites. In: Nash III ThomasH. ed. Lichen Biology. 2nd ed.. Cambridge: Cambridge University Press; 2008: 104-133
  Google Scholar
• 33 Huneck S, Yoshimura I. Identification of Lichen Substances. Berlin-Heidelberg: Springer; 1996: 493
  CrossrefGoogle Scholar
• 34 Culberson CF. Joint occurrence of a lichen depsidone and its probable depside precursor. Science 1964; 143: 255-256 DOI: 10.1126/science.143.3603.255.
  CrossrefPubMedGoogle Scholar
• 35 Erdtman HGH. The chemistry of forest, humic acids, lichens, lignans, lignins and conifers. Tappi 1962; 45: 14A 16A, 18A, 20A, 26A, 28A, 30A, 34A, 36A, 38A
  PubMedGoogle Scholar
• 36 Culberson WL, Culberson CF. The Lichen Genera Cetrelia and Platismatia (Parmeliaceae). Systematic Plant Studies. Contributions from the United States National Herbarium. Washington, DC: Smithsonian Institution Press; 1968: 449-558
  Google Scholar
• 37 Culberson CF. A note on the chemical strains of Pseudevernia furfuracea . Bryologist 1965; 68: 435-439
  CrossrefPubMedGoogle Scholar
• 38 Elix JA, Jenie UA, Parker JL. A novel synthesis of the lichen depsidones divaronic acid and stenosporonic acid, and the biosynthetic implications. Aust J Chem 1987; 40: 1451-1464
  CrossrefPubMedGoogle Scholar
• 39 Stocker-Wörgötter E. Metabolic diversity of lichen-forming ascomycetous fungi: culturing, polyketide and shikimate metabolite production, and PKS genes. Nat Prod Rep 2008; 25: 188-200 DOI: 10.1039/b606983p.
  CrossrefPubMedGoogle Scholar
• 40 Schmitt I, Martín MP, Kautz S, Lumbsch HT. Diversity of non-reducing polyketide synthase genes in the Pertusariales (lichenized Ascomycota): a phylogenetic perspective. Phytochemistry 2005; 66: 1241-1253 DOI: 10.1016/j.phytochem.2005.04.014.
  CrossrefPubMedGoogle Scholar
• 41 Armaleo D, Sun X, Culberson C. Insights from the first putative biosynthetic gene cluster for a lichen depside and depsidone. Mycologia 2011; 103: 741-754 DOI: 10.3852/10-335.
  CrossrefPubMedGoogle Scholar
• 42 Bertrand RL, Abdel-Hameed M, Sorensen JL. Lichen biosynthetic gene clusters. Part I. Genome sequencing reveals a rich biosynthetic potential. J Nat Prod 2018; 81: 723-731 DOI: 10.1021/acs.jnatprod.7b00769.
  CrossrefPubMedGoogle Scholar
• 43 Armaleo D, Müller O, Lutzoni F, Andrésson ÓS, Blanc G, Bode HB, Collart FR, Dal Grande F, Dietrich F, Grigoriev IV, Joneson S, Kuo A, Larsen PE, Logsdon Jr JM, Lopez D, Martin F, May SP, McDonald TR, Merchant SS, Miao V, Morin E, Oono R, Pellegrini M, Rubinstein N, Sanchez-Puerta MV, Savelkoul E, Schmitt I, Slot JC, Soanes D, Szövényi P, Talbot NJ, Veneault-Fourrey C, Xavier BB. The lichen symbiosis re-viewed through the genomes of Cladonia grayi and its algal partner Asterochloris glomerata . BMC Genom 2019; 20: 605 DOI: 10.1186/s12864-019-5629-x.
  CrossrefPubMedGoogle Scholar
• 44 Pizarro D, Divakar PK, Grewe F, Crespo A, Dal Grande F, Lumbsch HT. Genome-wide analysis of biosynthetic gene cluster reveals correlated gene loss with absence of usnic acid in lichen-forming fungi. Genome Biol Evol 2020; 12: 1858-1868 DOI: 10.1093/gbe/evaa189.
  CrossrefPubMedGoogle Scholar
• 45 Hunyadi A. The mechanism(s) of action of antioxidants: From scavenging reactive oxygen/nitrogen species to redox signaling and the generation of bioactive secondary metabolites. Med Res Rev 2019; 39: 2505-2533 DOI: 10.1002/med.21592.
  CrossrefPubMedGoogle Scholar
• 46 Manojlovic NT, Vasiljevic PJ, Maskovic PZ, Juskovic M, Bogdanovic-Dusanovic G. Chemical composition, antioxidant, and antimicrobial activities of lichen Umbilicaria cylindrica (L.) Delise (Umbilicariaceae). Evid Based Complement Alternat Med 2012; 2012: 452431 DOI: 10.1155/2012/452431.
  CrossrefPubMedGoogle Scholar
• 47 Williams D, Loganzo F, Whitney L, Togias J, Harrison R, Singh M, McDonald L, Chelvendran S, Andersen R. Depsides isolated from the Sri Lankan lichen Parmotrema sp. exhibit selective Plk1 inhibitory activity. Pharm Biol 2011; 49: 296-301 DOI: 10.3109/13880209.2010.517540.
  CrossrefPubMedGoogle Scholar
• 48 Hong JM, Suh SS, Kim TK, Kim JE, Han SJ, Youn UJ, Yim JH, Kim IC. Anti-cancer activity of lobaric acid and lobarstin extracted from the antarctic lichen Stereocaulon alpinum . Molecules 2018; 23: 658 DOI: 10.3390/molecules23030658.
  CrossrefPubMedGoogle Scholar
• 49 Huang Z. Bcl-2 family proteins as targets for anticancer drug design. Oncogene 2000; 19: 6627-6631 DOI: 10.1038/sj.onc.1204087.
  CrossrefPubMedGoogle Scholar
• 50 Emsen B, Ozdemir O, Engin T, Togar B, Cavusoglu S, Turkez H. Inhibition of growth of U87MG human glioblastoma cells by Usnea longissima Ach. An Acad Bras Cienc 2019; 91: e20180994 DOI: 10.1590/0001-3765201920180994.
  CrossrefPubMedGoogle Scholar
• 51 Wisastra R, Dekker FJ. Inflammation, cancer and oxidative lipoxygenase activity are intimately linked. Cancers (Basel) 2014; 6: 1500-1521 DOI: 10.3390/cancers6031500.
  CrossrefPubMedGoogle Scholar
• 52 Ebrahim HY, Elsayed HE, Mohyeldin MM, Akl MR, Bhattacharjee J, Egbert S, El Sayed KA. Norstictic acid inhibits breast cancer cell proliferation, migration, invasion, and in vivo invasive growth through targeting c-Met. Phytother Res 2016; 30: 557-566 DOI: 10.1002/ptr.5551.
  CrossrefPubMedGoogle Scholar
• 53 Zhang Y, Xia M, Jin K, Wang S, Wei H, Fan C, Wu Y, Li X, Li X, Li G, Zeng Z, Xiong W. Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities. Mol Cancer 2018; 17: 45 DOI: 10.1186/s12943-018-0796-y.
  CrossrefPubMedGoogle Scholar
• 54 Alam MK, Alhhazmi A, DeCoteau JF, Luo Y, Geyer CR. RecA inhibitors potentiate antibiotic activity and block evolution of antibiotic resistance. Cell Chem Biol 2016; 23: 381-391 DOI: 10.1016/j.chembiol.2016.02.010.
  CrossrefPubMedGoogle Scholar
• 55 McGillick BE, Kumaran D, Vieni C, Swaminathan S. β-Hydroxyacyl-acyl carrier protein dehydratase (FabZ) from Francisella tularensis and Yersinia pestis: structure determination, enzymatic characterization, and cross-inhibition studies. Biochemistry 2016; 55: 1091-1099 DOI: 10.1021/acs.biochem.5b00832.
  CrossrefPubMedGoogle Scholar
• 56 Feibelman KM, Fuller BP, Li L, LaBarbera DV, Geiss BJ. Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme. Antiviral Res 2018; 154: 124-131 DOI: 10.1016/j.antiviral.2018.03.013.
  CrossrefPubMedGoogle Scholar
• 57 Panzhinskiy E, Ren J, Nair S. Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus. Curr Med Chem 2013; 20: 2609-2625 DOI: 10.2174/0929867311320210001.
  CrossrefPubMedGoogle Scholar
• 58 Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, Kahn BB. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 2000; 20: 5479-5489 DOI: 10.1128/mcb.20.15.5479-5489.2000.
  CrossrefPubMedGoogle Scholar
• 59 Carpentier C, Barbeau X, Azelmat J, Vaillancourt K, Grenier D, Lagüe P, Voyer N. Lobaric acid and pseudodepsidones inhibit NF-κB signaling pathway by activation of PPAR-γ. Bioorg Med Chem 2018; 26: 5845-5851 DOI: 10.1016/j.bmc.2018.10.035.
  CrossrefPubMedGoogle Scholar
• 60 Lee HW, Kim J, Yim JH, Lee HK, Pyo S. Anti-inflammatory activity of lobaric acid via suppressing NF-κB/MAPK pathways or NLRP3 inflammasome activation. Planta Med 2019; 85: 302-311 DOI: 10.1055/a-0777-2420.
  Article in Thieme ConnectPubMedGoogle Scholar
• 61 Millot M, Tomasi S, Articus K, Rouaud I, Bernard A, Boustie J. Metabolites from the lichen Ochrolechia parella growing under two different heliotropic conditions. J Nat Prod 2007; 70: 316-318 DOI: 10.1021/np060561p.
  CrossrefPubMedGoogle Scholar
• 62 Bellio P, Segatore B, Mancini A, Di Pietro L, Bottoni C, Sabatini A, Brisdelli F, Piovano M, Nicoletti M, Amicosante G, Perilli M, Celenza G. Interaction between lichen secondary metabolites and antibiotics against clinical isolates methicillin-resistant Staphylococcus aureus strains. Phytomedicine 2015; 22: 223-230 DOI: 10.1016/j.phymed.2014.12.005.
  CrossrefPubMedGoogle Scholar
• 63 Bellio P, Di Pietro L, Mancini A, Piovano M, Nicoletti M, Brisdelli F, Tondi D, Cendron L, Franceschini N, Amicosante G, Perilli M, Celenza G. SOS response in bacteria: Inhibitory activity of lichen secondary metabolites against Escherichia coli RecA protein. Phytomedicine 2017; 29: 11-18 DOI: 10.1016/j.phymed.2017.04.001.
  CrossrefPubMedGoogle Scholar
• 64 Yilmaz M, Türk AO, Tay T, Kivanç M. The antimicrobial activity of extracts of the lichen Cladonia foliacea and its (−)-usnic acid, atranorin, and fumarprotocetraric acid constituents. Z Naturforsch C J Biosci 2004; 59: 249-254 DOI: 10.1515/znc-2004-3-423.
  CrossrefPubMedGoogle Scholar
• 65 Ranković B, Misić M, Sukdolak S. Antimicrobial activity of extracts of the lichens Cladonia furcata, Parmelia caperata, Parmelia pertusa, Hypogymnia physodes and Umbilicaria polyphylla . Br J Biomed Sci 2007; 64: 143-148 DOI: 10.1080/09674845.2007.11732776.
  CrossrefPubMedGoogle Scholar
• 66 Pompilio A, Pomponio S, Di Vincenzo V, Crocetta V, Nicoletti M, Piovano M, Garbarino JA, Di Bonaventura G. Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients. Future Microbiol 2013; 8: 281-292 DOI: 10.2217/fmb.12.142.
  CrossrefPubMedGoogle Scholar
• 67 Igoli JO, Gray AI, Clements CJ, Kantheti P, Singla RH. Antitrypanosomal activity & docking studies of isolated constituents from the lichen Cetraria islandica: possibly multifunctional scaffolds. Curr Top Med Chem 2014; 14: 1014-1021 DOI: 10.2174/1568026614666140324122323.
  CrossrefPubMedGoogle Scholar
• 68 Fernández-Moriano C, Divakar PK, Crespo A, Gómez-Serranillos MP. In vitro neuroprotective potential of lichen metabolite fumarprotocetraric acid via intracellular redox modulation. Toxicol Appl Pharmacol 2017; 316: 83-94 DOI: 10.1016/j.taap.2016.12.020.
  CrossrefPubMedGoogle Scholar
• 69 de Barros Alves GM, de Sousa Maia MB, de Souza Franco E, Galvão AM, da Silva TG, Gomes RM, Martins MB, da Silva Falcão EP, de Castro CM, da Silva NH. Expectorant and antioxidant activities of purified fumarprotocetraric acid from Cladonia verticillaris lichen in mice. Pulm Pharmacol Ther 2014; 27: 139-143 DOI: 10.1016/j.pupt.2013.07.002.
  CrossrefPubMedGoogle Scholar
• 70 Lohézic-Le Dévéhat F, Legouin B, Couteau C, Boustie J, Coiffard L. Lichenic extracts and metabolites as UV filters. J Photochem Photobiol B 2013; 120: 17-28 DOI: 10.1016/j.jphotobiol.2013.01.009.
  CrossrefPubMedGoogle Scholar
• 71 Pavlovic V, Stojanovic I, Jadranin M, Vajs V, Djordjević I, Smelcerovic A, Stojanovic G. Effect of four lichen acids isolated from Hypogymnia physodes on viability of rat thymocytes. Food Chem Toxicol 2013; 51: 160-164 DOI: 10.1016/j.fct.2012.04.043.
  CrossrefPubMedGoogle Scholar
• 72 Cetin H, Tufan-Cetin O, Turk AO, Tay T, Candan M, Yanikoglu A, Sumbul H. Larvicidal activity of some secondary lichen metabolites against the mosquito Culiseta longiareolata Macquart (Diptera: Culicidae). Nat Prod Res 2012; 26: 350-355 DOI: 10.1080/14786411003774296.
  CrossrefPubMedGoogle Scholar
• 73 Yilmaz M, Tay T, Kivanç M, Türk H, Türk AO. The antimicrobial activity of extracts of the lichen Hypogymnia tubulosa and its 3-hydroxyphysodic acid constituent. Z Naturforsch C J Biosci 2005; 60: 35-38 DOI: 10.1515/znc-2005-1-207.
  CrossrefPubMedGoogle Scholar
• 74 Ogmundsdóttir HM, Zoëga GM, Gissurarson SR, Ingólfsdóttir K. Anti-proliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell-lines and mitogen-stimulated lymphocytes. J Pharm Pharmacol 1998; 50: 107-115 DOI: 10.1111/j.2042-7158.1998.tb03312.x.
  CrossrefPubMedGoogle Scholar
• 75 Bucar F, Schneider I, Ogmundsdóttir H, Ingólfsdóttir K. Anti-proliferative lichen compounds with inhibitory activity on 12(S)-HETE production in human platelets. Phytomedicine 2004; 11: 602-606 DOI: 10.1016/j.phymed.2004.03.004.
  CrossrefPubMedGoogle Scholar
• 76 Brisdelli F, Perilli M, Sellitri D, Piovano M, Garbarino JA, Nicoletti M, Bozzi A, Amicosante G, Celenza G. Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study. Phytother Res 2013; 27: 431-437 DOI: 10.1002/ptr.4739.
  CrossrefPubMedGoogle Scholar
• 77 Haraldsdóttir S, Guolaugsdóttir E, Ingólfsdóttir K, Ogmundsdóttir HM. Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro . Planta Med 2004; 70: 1098-1100 DOI: 10.1055/s-2004-832657.
  Article in Thieme ConnectPubMedGoogle Scholar
• 78 Morita H, Tsuchiya T, Kishibe K, Noya S, Shiro M, Hirasawaa Y. Antimitotic activity of lobaric acid and a new benzofuran, sakisacaulon A from Stereocaulon sasakii . Bioorg Med Chem Lett 2009; 19: 3679-3681 DOI: 10.1016/j.bmcl.2009.03.170.
  CrossrefPubMedGoogle Scholar
• 79 Ozgencli I, Budak H, Ciftci M, Anar M. Lichen acids may be used as a potential drug for cancer therapy; by inhibiting mitochondrial thioredoxin reductase purified from rat lung. Anticancer Agents Med Chem 2018; 18: 1599-1605 DOI: 10.2174/1871520618666180525095520.
  CrossrefPubMedGoogle Scholar
• 80 Seo C, Sohn JH, Ahn JS, Yim JH, Lee HK, Oh H. Protein tyrosine phosphatase 1B inhibitory effects of depsidone and pseudodepsidone metabolites from the antarctic lichen Stereocaulon alpinum . Bioorg Med Chem Lett 2009; 19: 2801-2803 DOI: 10.1016/j.bmcl.2009.03.108.
  CrossrefPubMedGoogle Scholar
• 81 Kim TK, Kim JE, Youn UJ, Han SJ, Kim IC, Cho CG, Yim JH. Total syntheses of lobaric acid and its derivatives from the antarctic lichen Stereocaulon alpinum . J Nat Prod 2018; 81: 1460-1467 DOI: 10.1021/acs.jnatprod.8b00227.
  CrossrefPubMedGoogle Scholar
• 82 Joo YA, Chung H, Yoon S, Park JI, Lee JE, Myung CH, Hwang JS. Skin barrier recovery by Protease-Activated Receptor-2 antagonist lobaric acid. Biomol Ther (Seoul) 2016; 24: 529-535 DOI: 10.4062/biomolther.2016.011.
  CrossrefPubMedGoogle Scholar
• 83 Kwon IS, Yim JH, Lee HK, Pyo S. Lobaric acid inhibits VCAM-1 expression in TNF-α-stimulated vascular smooth muscle cells via modulation of NF-κB and MAPK signaling pathways. Biomol Ther (Seoul) 2016; 24: 25-32 DOI: 10.4062/biomolther.2015.084.
  CrossrefPubMedGoogle Scholar
• 84 Ingolfsdottir K, Gissurarson SR, Müller-Jakic B, Breu W, Wagner H. Inhibitory effects of the lichen metabolite lobaric acid on arachidonate metabolism in vitro . Phytomedicine 1996; 2: 243-246 DOI: 10.1016/S0944-7113(96)80049-3.
  CrossrefPubMedGoogle Scholar
• 85 Ingólfsdóttir K, Chung GA, Skúlason VG, Gissurarson SR, Vilhelmsdóttir M. Antimycobacterial activity of lichen metabolites in vitro . Eur J Pharm Sci 1998; 6: 141-144 DOI: 10.1016/s0928-0987(97)00078-x.
  CrossrefPubMedGoogle Scholar
• 86 Vankadari N, Jeyasankar NN, Lopes WJ. Structure of the SARS-CoV-2 Nsp1/5′-untranslated region complex and implications for potential therapeutic targets, a vaccine, and virulence. J Phys Chem Lett 2020; 11: 9659-9668 DOI: 10.1021/acs.jpclett.0c02818.
  CrossrefPubMedGoogle Scholar
• 87 Thadhani VM, Choudhary MI, Ali S, Omar I, Siddique H, Karunaratne V. Antioxidant activity of some lichen metabolites. Nat Prod Res 2011; 25: 1827-1837 DOI: 10.1080/14786419.2010.529546.
  CrossrefPubMedGoogle Scholar
• 88 Gissurarson SR, Sigurdsson SB, Wagner H, Ingolfsdottir K. Effect of lobaric acid on cysteinyl-leukotriene formation and contractile activity of guinea pig taenia coli . J Pharmacol Exp Ther 1997; 280: 770-773
  PubMedGoogle Scholar
• 89 Brandão LF, Alcantara GB, Matos Mde F, Bogo D, Freitas Ddos S, Oyama NM, Honda NK. Cytotoxic evaluation of phenolic compounds from lichens against melanoma cells. Chem Pharm Bull (Tokyo) 2013; 61: 176-183 DOI: 10.1248/cpb.c12-00739.
  CrossrefPubMedGoogle Scholar
• 90 Ranković B, Kosanić M, Stanojković T, Vasiljević P, Manojlović N. Biological activities of Toninia candida and Usnea barbata together with their norstictic acid and usnic acid constituents. Int J Mol Sci 2012; 13: 14707-14722 DOI: 10.3390/ijms131114707.
  CrossrefPubMedGoogle Scholar
• 91 Ismed F, Dévéhat FL, Rouaud I, Ferron S, Bakhtiar A, Boustie J. NMR reassignment of stictic acid isolated from a Sumatran lichen Stereocaulon montagneanum (Stereocaulaceae) with superoxide anion scavenging activities. Z Naturforsch C J Biosci 2017; 72: 55-62 DOI: 10.1515/znc-2016-0148.
  CrossrefPubMedGoogle Scholar
• 92 Tay T, Türk AO, Yilmaz M, Türk H, Kivanç M. Evaluation of the antimicrobial activity of the acetone extract of the lichen Ramalina farinacea and its (+)-usnic acid, norstictic acid, and protocetraric acid constituents. Z Naturforsch C J Biosci 2004; 59: 384-388 DOI: 10.1515/znc-2004-5-617.
  CrossrefPubMedGoogle Scholar
• 93 Honda NK, Pavan FR, Coelho RG, de Andrade Leite SR, Micheletti AC, Lopes TI, Misutsu MY, Beatriz A, Brum RL, Leite CQ. Antimycobacterial activity of lichen substances. Phytomedicine 2010; 17: 328-332 DOI: 10.1016/j.phymed.2009.07.018.
  CrossrefPubMedGoogle Scholar
• 94 Russo A, Piovano M, Lombardo L, Vanella L, Cardile V, Garbarino J. Pannarin inhibits cell growth and induces cell death in human prostate carcinoma DU-145 cells. Anticancer Drugs 2006; 17: 1163-1169 DOI: 10.1097/01.cad.0000236310.66080.ed.
  CrossrefPubMedGoogle Scholar
• 95 Russo A, Piovano M, Lombardo L, Garbarino J, Cardile V. Lichen metabolites prevent UV light and nitric oxide-mediated plasmid DNA damage and induce apoptosis in human melanoma cells. Life Sci 2008; 83: 468-474 DOI: 10.1016/j.lfs.2008.07.012.
  CrossrefPubMedGoogle Scholar
• 96 Hidalgo ME, Fernández E, Quilhot W, Lissi EA. Photohemolytic activity of lichen metabolites. J Photochem Photobiol B 1993; 21: 37-40 DOI: 10.1016/1011-1344(93)80161-2.
  CrossrefPubMedGoogle Scholar
• 97 Celenza G, Segatore B, Setacci D, Bellio P, Brisdelli F, Piovano M, Garbarino JA, Nicoletti M, Perilli M, Amicosante G. In vitro antimicrobial activity of pannarin alone and in combination with antibiotics against methicillin-resistant Staphylococcus aureus clinical isolates. Phytomedicine 2012; 19: 596-602 DOI: 10.1016/j.phymed.2012.02.010.
  CrossrefPubMedGoogle Scholar
• 98 Fournet A, Ferreira ME, Rojas de Arias A, Torres de Ortiz S, Inchausti A, Yaluff G, Quilhot W, Fernandez E, Hidalgo ME. Activity of compounds isolated from Chilean lichens against experimental cutaneous leishmaniasis. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1997; 116: 51-54 DOI: 10.1016/s0742-8413(96)00127-2.
  CrossrefPubMedGoogle Scholar
• 99 Fernández E, Reyes A, Hidalgo ME, Quilhot W. Photoprotector capacity of lichen metabolites assessed through the inhibition of the 8-methoxypsoralen photobinding to protein. J Photochem Photobiol B 1998; 42: 195-201 DOI: 10.1016/s1011-1344(98)00070-0.
  CrossrefPubMedGoogle Scholar
• 100 Cardile V, Graziano ACE, Avola R, Piovano M, Russo A. Potential anticancer activity of lichen secondary metabolite physodic acid. Chem Biol Interact 2017; 263: 36-45 DOI: 10.1016/j.cbi.2016.12.007.
  CrossrefPubMedGoogle Scholar
• 101 Kosanić M, Manojlović N, Janković S, Stanojković T, Ranković B. Evernia prunastri and Pseudoevernia furfuraceae lichens and their major metabolites as antioxidant, antimicrobial and anticancer agents. Food Chem Toxicol 2013; 53: 112-118 DOI: 10.1016/j.fct.2012.11.034.
  CrossrefPubMedGoogle Scholar
• 102 Studzińska-Sroka E, Piotrowska H, Kucińska M, Murias M, Bylka W. Cytotoxic activity of physodic acid and acetone extract from Hypogymnia physodes against breast cancer cell lines. Pharm Biol 2016; 54: 2480-2485 DOI: 10.3109/13880209.2016.1160936.
  CrossrefPubMedGoogle Scholar
• 103 Emsen B, Aslan A, Togar B, Turkez H. In vitro antitumor activities of the lichen compounds olivetoric, physodic and psoromic acid in rat neuron and glioblastoma cells. Pharm Biol 2016; 54: 1748-1762 DOI: 10.3109/13880209.2015.1126620.
  CrossrefPubMedGoogle Scholar
• 104 Stojanović IZ, Stanković M, Jovanović O, Petrović G, Smelcerović A, Stojanović GS. Effect of Hypogymnia physodes extracts and their depsidones on micronucleus distribution in human lymphocytes. Nat Prod Commun 2013; 8: 109-112
  PubMedGoogle Scholar
• 105 Stojanović IZ, Najman S, Jovanović O, Petrović G, Najdanović J, Vasiljević P, Smelcerović A. Effects of depsidones from Hypogymnia physodes on HeLa cell viability and growth. Folia Biol (Praha) 2014; 60: 89-94
  PubMedGoogle Scholar
• 106 Talapatra SK, Rath O, Clayton E, Tomasi S, Kozielski F. Depsidones from lichens as natural product inhibitors of M-Phase Phosphoprotein 1, a human kinesin required for cytokinesis. J Nat Prod 2016; 79: 1576-1585 DOI: 10.1021/acs.jnatprod.5b00962.
  CrossrefPubMedGoogle Scholar
• 107 Bauer J, Waltenberger B, Noha SM, Schuster D, Rollinger JM, Boustie J, Chollet M, Stuppner H, Werz O. Discovery of depsides and depsidones from lichen as potent inhibitors of microsomal prostaglandin E2 synthase-1 using pharmacophore models. ChemMedChem 2012; 7: 2077-2081 DOI: 10.1002/cmdc.201200345.
  CrossrefPubMedGoogle Scholar
• 108 Emsen B, Turkez H, Togar B, Aslan A. Evaluation of antioxidant and cytotoxic effects of olivetoric and physodic acid in cultured human amnion fibroblasts. Hum Exp Toxicol 2017; 36: 376-385 DOI: 10.1177/0960327116650012.
  CrossrefPubMedGoogle Scholar
• 109 Emsen B, Togar B, Turkez H, Aslan A. Effects of two lichen acids isolated from Pseudevernia furfuracea (L.) Zopf in cultured human lymphocytes. Z Naturforsch C J Biosci 2018; 73: 303-312 DOI: 10.1515/znc-2017-0209.
  CrossrefPubMedGoogle Scholar
• 110 Reddy RG, Veeraval L, Maitra S, Chollet-Krugler M, Tomasi S, Dévéhat FL, Boustie J, Chakravarty S. Lichen-derived compounds show potential for central nervous system therapeutics. Phytomedicine 2016; 23: 1527-1534 DOI: 10.1016/j.phymed.2016.08.010.
  CrossrefPubMedGoogle Scholar
• 111 Osawa T, Kumon H, Reece CA, Shibamoto T. Inhibitory effect of lichen constituents on mutagenicity induced by heterocyclic amines. Environ Mol Mutagen 1991; 18: 35-40 DOI: 10.1002/em.2850180107.
  CrossrefPubMedGoogle Scholar
• 112 Nishanth KS, Sreerag RS, Deepa I, Mohandas C, Nambisan B. Protocetraric acid: an excellent broad spectrum compound from the lichen Usnea albopunctata against medically important microbes. Nat Prod Res 2015; 29: 574-577 DOI: 10.1080/14786419.2014.953500.
  CrossrefPubMedGoogle Scholar
• 113 Dieu A, Mambu L, Champavier Y, Chaleix V, Sol V, Gloaguen V, Millot M. Antibacterial activity of the lichens Usnea Florida and Flavoparmelia caperata (Parmeliaceae). Nat Prod Res 2020; 34: 3358-3362 DOI: 10.1080/14786419.2018.1561678.
  CrossrefPubMedGoogle Scholar
• 114 Deraeve C, Guo Z, Bon RS, Blankenfeldt W, DiLucrezia R, Wolf A, Menninger S, Stigter EA, Wetzel S, Choidas A, Alexandrov K, Waldmann H, Goody RS, Wu YW. Psoromic acid is a selective and covalent Rab-prenylation inhibitor targeting autoinhibited RabGGTase. J Am Chem Soc 2012; 134: 7384-7391 DOI: 10.1021/ja211305j.
  CrossrefPubMedGoogle Scholar
• 115 Samatov TR, Wolf A, Odenwälder P, Bessonov S, Deraeve C, Bon RS, Waldmann H, Lührmann R. Psoromic acid derivatives: a new family of small-molecule pre-mRNA splicing inhibitors discovered by a stage-specific high-throughput in vitro splicing assay. Chembiochem 2012; 13: 640-644 DOI: 10.1002/cbic.201100790.
  CrossrefPubMedGoogle Scholar
• 116 Hassan STS, Šudomová M, Berchová-Bímová K, Šmejkal K, Echeverría J. Psoromic acid, a lichen-derived molecule, inhibits the replication of HSV-1 and HSV-2, and inactivates HSV-1 DNA polymerase: shedding light on antiherpetic properties. Molecules 2019; 24: 2912 DOI: 10.3390/molecules24162912.
  CrossrefPubMedGoogle Scholar
• 117 Sweidan A, Chollet-Krugler M, Sauvager A, van de Weghe P, Chokr A, Bonnaure-Mallet M, Tomasi S, Bousarghin L. Antibacterial activities of natural lichen compounds against Streptococcus gordonii and Porphyromonas gingivalis . Fitoterapia 2017; 121: 164-169 DOI: 10.1016/j.fitote.2017.07.011.
  CrossrefPubMedGoogle Scholar
• 118 Hassan STS, Šudomová M, Berchová-Bímová K, Gowrishankar S, Rengasamy KRR. Antimycobacterial, enzyme inhibition, and molecular interaction studies of psoromic acid in Mycobacterium tuberculosis: efficacy and safety investigations. J Clin Med 2018; 7: 226 DOI: 10.3390/jcm7080226.
  CrossrefPubMedGoogle Scholar
• 119 Lauinger IL, Vivas L, Perozzo R, Stairiker C, Tarun A, Zloh M, Zhang X, Xu H, Tonge PJ, Franzblau SG, Pham DH, Esguerra CV, Crawford AD, Maes L, Tasdemir D. Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target. J Nat Prod 2013; 76: 1064-1070 DOI: 10.1021/np400083k.
  CrossrefPubMedGoogle Scholar
• 120 Behera BC, Mahadik N, Morey M. Antioxidative and cardiovascular-protective activities of metabolite usnic acid and psoromic acid produced by lichen species Usnea complanata under submerged fermentation. Pharm Biol 2012; 50: 968-979 DOI: 10.3109/13880209.2012.654396.
  CrossrefPubMedGoogle Scholar
• 121 Candan M, Yilmaz M, Tay T, Erdem M, Türk AO. Antimicrobial activity of extracts of the lichen Parmelia sulcata and its salazinic acid constituent. Z Naturforsch C J Biosci 2007; 62: 619-621 DOI: 10.1515/znc-2007-7-827.
  CrossrefPubMedGoogle Scholar
• 122 Goel M, Dureja P, Rani A, Uniyal PL, Laatsch H. Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl. J Agric Food Chem 2011; 59: 2299-2307 DOI: 10.1021/jf1049613.
  CrossrefPubMedGoogle Scholar
• 123 Gaikwad S, Verma N, Sharma BO, Behera BC. Growth promoting effects of some lichen metabolites on probiotic bacteria. J Food Sci Technol 2014; 51: 2624-2631 DOI: 10.1007/s13197-012-0785-x.
  CrossrefPubMedGoogle Scholar
• 124 de Paz GA, Raggio J, Gómez-Serranillos MP, Palomino OM, González-Burgos E, Carretero ME, Crespo A. HPLC isolation of antioxidant constituents from Xanthoparmelia spp. J Pharm Biomed Anal 2010; 53: 165-171 DOI: 10.1016/j.jpba.2010.04.013.
  CrossrefPubMedGoogle Scholar
• 125 Burlando B, Ranzato E, Volante A, Appendino G, Pollastro F, Verotta L. Antiproliferative effects on tumor cells and promotion of keratinocyte wound healing by different lichen compounds. Planta Med 2009; 75: 607-613 DOI: 10.1055/s-0029-1185329.
  Article in Thieme ConnectPubMedGoogle Scholar
• 126 Papadopoulou P, Tzakou O, Vagias C, Kefalas P, Roussis V. Beta-orcinol metabolites from the lichen Hypotrachyna revoluta . Molecules 2007; 12: 997-1005 DOI: 10.3390/12050997.
  CrossrefPubMedGoogle Scholar
• 127 Wassman CD, Baronio R, Demir Ö, Wallentine BD, Chen CK, Hall LV, Salehi F, Lin DW, Chung BP, Hatfield GW, Richard Chamberlin A, Luecke H, Lathrop RH, Kaiser P, Amaro RE. Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53. Nat Commun 2013; 4: 1407 DOI: 10.1038/ncomms2361.
  CrossrefPubMedGoogle Scholar
• 128 Omar SI, Tuszynski J. Ranking the binding energies of p53 mutant activators and their ADMET properties. Chem Biol Drug Des 2015; 86: 163-172 DOI: 10.1111/cbdd.12480.
  CrossrefPubMedGoogle Scholar
• 129 Russo A, Caggia S, Piovano M, Garbarino J, Cardile V. Effect of vicanicin and protolichesterinic acid on human prostate cancer cells: role of Hsp70 protein. Chem Biol Interact 2012; 195: 1-10 DOI: 10.1016/j.cbi.2011.10.005.
  CrossrefPubMedGoogle Scholar
• 130 Sanjaya A, Avidlyandi A, Adfa M, Ninomiya M, Koketsu M. A new depsidone from Teloschistes flavicans and the antileukemic activity. J Oleo Sci 2020; 69: 1591-1595 DOI: 10.5650/jos.ess20209.
  CrossrefPubMedGoogle Scholar
• 131 Bay MV, Nam PC, Quang DT, Mechler A, Hien NK, Hoa NT, Vo QV. Theoretical study on the antioxidant activity of natural depsidones. ACS Omega 2020; 5: 7895-7902 DOI: 10.1021/acsomega.9b04179.
  CrossrefPubMedGoogle Scholar
• 132 Leal A, Rojas JL, Valencia-Islas NA, Castellanos L. New β-orcinol depsides from Hypotrachyna caraccensis, a lichen from the páramo ecosystem and their free radical scavenging activity. Nat Prod Res 2018; 32: 1375-1382 DOI: 10.1080/14786419.2017.1346639.
  CrossrefPubMedGoogle Scholar
• 133 Bui VM, Duong TH, Chavasiri W, Nguyen KP, Huynh BL. A new depsidone from the lichen Usnea ceratina . Nat Prod Res 2020; DOI: 10.1080/14786419.2020.1828405.
  CrossrefPubMedGoogle Scholar